NasdaqGS - Delayed Quote USD

BioMarin Pharmaceutical Inc. (BMRN)

Compare
64.26 +0.81 (+1.28%)
At close: 4:00 PM EST
64.26 0.00 (0.00%)
After hours: 4:20 PM EST

Valuation Measures

Annual
Monthly
Currency in USD
Download
Current9/30/20246/30/20243/31/202412/31/20239/30/2023
Market Cap 12.09B 13.39B 15.63B 16.57B 18.16B 16.65B
Enterprise Value 11.76B 13.27B 15.68B 16.60B 18.13B 16.57B
Trailing P/E 38.22 53.25 77.67 100.39 125.22 170.15
Forward P/E 16.45 17.18 30.96 32.57 35.46 30.86
PEG Ratio (5yr expected) 0.40 0.42 0.71 0.72 0.72 1.01
Price/Sales 4.44 5.28 6.42 6.92 7.97 7.55
Price/Book 2.23 2.53 3.09 3.35 3.71 3.48
Enterprise Value/Revenue 4.27 5.13 6.35 6.86 7.85 7.42
Enterprise Value/EBITDA 23.22 31.49 43.65 53.59 67.65 73.83
9/30/2023 - 7/26/1999

Upgrade to begin using 40 years of earnings data and get so much more.

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

Upgrade

Financial Highlights

Fiscal Year

Fiscal Year Ends 12/31/2023
Most Recent Quarter (mrq) 9/30/2024

Profitability

Profit Margin 11.71%
Operating Margin (ttm) 15.27%

Management Effectiveness

Return on Assets (ttm) 3.00%
Return on Equity (ttm) 6.25%

Income Statement

Revenue (ttm) 2.75B
Revenue Per Share (ttm) 14.53
Quarterly Revenue Growth (yoy) 28.30%
Gross Profit (ttm) --
EBITDA 426.09M
Net Income Avi to Common (ttm) 322.29M
Diluted EPS (ttm) 1.66
Quarterly Earnings Growth (yoy) 162.70%

Balance Sheet

Total Cash (mrq) 930.44M
Total Cash Per Share (mrq) 4.88
Total Debt (mrq) 602.69M
Total Debt/Equity (mrq) 11.13%
Current Ratio (mrq) 4.27
Book Value Per Share (mrq) 28.41

Cash Flow Statement

Operating Cash Flow (ttm) 414.7M
Levered Free Cash Flow (ttm) 144.67M

Trading Information

Stock Price History

Beta (5Y Monthly) 0.31
52 Week Range 3 -28.05%
S&P 500 52-Week Change 3 30.47%
52 Week High 3 99.56
52 Week Low 3 61.15
50-Day Moving Average 3 68.67
200-Day Moving Average 3 81.08

Share Statistics

Avg Vol (3 month) 3 1.76M
Avg Vol (10 day) 3 1.42M
Shares Outstanding 5 190.58M
Implied Shares Outstanding 6 190.58M
Float 8 179.19M
% Held by Insiders 1 0.88%
% Held by Institutions 1 97.46%
Shares Short (10/31/2024) 4 5.38M
Short Ratio (10/31/2024) 4 3.92
Short % of Float (10/31/2024) 4 2.84%
Short % of Shares Outstanding (10/31/2024) 4 2.82%
Shares Short (prior month 9/30/2024) 4 5.28M

Dividends & Splits

Forward Annual Dividend Rate 4 --
Forward Annual Dividend Yield 4 --
Trailing Annual Dividend Rate 3 0.00
Trailing Annual Dividend Yield 3 0.00%
5 Year Average Dividend Yield 4 --
Payout Ratio 4 0.00%
Dividend Date 3 --
Ex-Dividend Date 4 --
Last Split Factor 2 --
Last Split Date 3 --

Footnotes

  • 1 Data provided by Refinitiv.
  • 2 Data provided by EDGAR Online.
  • 3 Data derived from multiple sources or calculated by Yahoo Finance.
  • 4 Data provided by Morningstar, Inc.
  • 5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
  • 6 Implied Shares Outstanding of common equity, assuming the conversion of all convertible subsidiary equity into common.
  • 7 EBITDA is calculated by S&P Global Market Intelligence using methodology that may differ from that used by a company in its reporting.
  • 8 A company's float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which may not be publicly traded.

Abbreviation Guide

  • mrq?=?Most Recent Quarter
  • ttm?=?Trailing Twelve Months
  • yoy?=?Year Over Year
  • lfy?=?Last Fiscal Year
  • fye?=?Fiscal Year Ending

Related Tickers